Abstract
We identify a new mechanism mediating capsule production and virulence in the WHO and CDC priority ESKAPE pathogen Acinetobacter baumannii. Non-capsulated and avirulent bacteria can revert into a capsulated and virulent state upon scarless excision of an ISAba13 insertion sequence under stress conditions. Reversion events fully restore capsule production and in vivo virulence. This increases our knowledge about A. baumannii genome dynamics, and the regulation of capsule production, virulence and resistance.
Original language | English |
---|---|
Pages (from-to) | 1473-1477 |
Number of pages | 5 |
Journal | ISME Journal |
Volume | 16 |
Issue number | 5 |
DOIs | |
Publication status | Published - May 2022 |
Funding
This project was supported by the Flanders Institute for Biotechnology (VIB) and has received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No 748032 (CV). AB is recipient of a PhD fellowship Strategic Basic Research of the Research Foundation – Flanders (FWO, File number: 77258).